Advertisement

Virushepatitiden bei Tieren

Conference paper
  • 7 Downloads
Part of the Verhandlungen der Deutschen Gesellschaft für innere Medizin book series (VDGINNERE, volume 82)

Zusammenfassung

Unsere Erkenntnisse über die Pathogenese von Virusinfektionen beim Menschen basieren in der Hauptsache auf klinischen und pathologisch-anatomischen Beobachtungen natürlicher Erkrankungen und auf Analogieschlüssen, die auf Erfahrungen beruhen, die bei Tierversuchen gewonnen wurden. Untersuchungen an natürlichen und experimentellen Infektionen beim Tier können Hinweise auf Pathogenitätsmechanismen von Virusinfektionen beim Menschen geben. Das dürfte auch der Grund dafür sein, warum die Organisatoren dieses Kongresses einen Veterinärvirologen aufgefordert haben, in diesem Kreis über Virushepatitiden beim Tier zu referieren.

Literatur

  1. Aubertin, A., Hirth, C, Travo, C, Nonnenmacher, H., Kirn, A.: Preparation and properties of an inhibitory extract from frog virus 3 particles. J. Virol. 11, 694 (1973).PubMedGoogle Scholar
  2. Bingen-Brendel, A., Batzenschlager, A., Gut, J. P., Hirth, C., Vetter, J. M., Kirn, A.: Etude histologique et virologique de l’hepatite degenerative argue provoquée par le FV3 (frog virus 3) chez la souris. Ann. Inst. Pasteur 122, 125 (1972).Google Scholar
  3. Blanden, R. V.: Mechanisms of recovery from a generalized viral infection: Mousepox. The effect of anti-thymocyte serum. J. exp. Med. 132, 1035 (1970).PubMedCrossRefGoogle Scholar
  4. Blanden, R. V.: Mechanisms of recovery from a generalized viral infection: Mousepox. Regression of infectious foci. J. exp. Med. 133, 1090 (1971).PubMedCrossRefGoogle Scholar
  5. Blanden, R. V.: Mechanisms of recovery from a generalized viral infection: Mousepox. Passive transfer of recovery mechanisms with immune lymphoid cells. J. exp. Med. 133, 1074 (1971).PubMedCrossRefGoogle Scholar
  6. Chany, C: Enhancing effect of the sarcoma virus in the replication of the mouse hepatitis virus in vitro. Proc. Soc. exp. Biol. Med. 131, 30 (1969).PubMedGoogle Scholar
  7. Datta, D. V., Isselbacher, K. J.: Effect of corticosteroides on mouse hepatitis virus infection. Gut 10, 552 (1969).CrossRefGoogle Scholar
  8. Elharrar, M., Hirth, C, Blanc, J., Kirn, A.: Pathogénie de l’hépatite toxique de la souris provoquée par le FV3 (frog virus 3). Inhibition de la synthèse des macromolécules du foie. Biochim. Biophys. Acta 319, 91 (1973).PubMedCrossRefGoogle Scholar
  9. Fujiwara, K.: Problems in checking inapparent infections in laboratory mouse colonies. An attempt at serological checking by anamnestic response. In: Defining of the Laboratory Animals, pp. 77–92. Washington, D.C.: Natl. Acad. Sci. 1969.Google Scholar
  10. Gallily, R., Warwick, A., Bang, F. B.: Effect of cortisone on genetic resistance to mouse hepatitis virus in vivo and in vitro. Proc. nat. Acad. Sci. 51, 1158 (1964).PubMedCrossRefGoogle Scholar
  11. Gledhill, A. W.: Enhancement of the pathogenicity of mouse hepatitis virus (MHV3) by prior infection of mice with certain leukaemic agents. Brit. J. Cancer 15, 531 (1961).PubMedCrossRefGoogle Scholar
  12. Gledhill, A. W.: Viral diseases in laboratory animals. In: The Problems of Laboratory Animal Disease. pp. 99–113. (Hrsg. R. J. C. Harris). London-New York: Academic Press 1962.Google Scholar
  13. Haller, O.: A normal hepatropic variant of influenza virus. Arch. Virology 49, 99 (1975).CrossRefGoogle Scholar
  14. Hirano, N., Takenaka, S., Fujiwara, K.: Pathogenicity of mouse hepatitis virus for mice depending upon host age and route of infection. Japan. J. exp. Med. 45, 285 (1975).Google Scholar
  15. Hirano, N., Tamaru, T., Taguchi, F., Ueda, K., Fujiwara, K.: Isolation of low-virulent mouse hepatitis virus from nude mice with wasting syndrome and hepatitis. Japan. J. exp. Med. 45, 429 (1975).Google Scholar
  16. Ishak, K. G.: Viral hepatitis: The morphologic spectrum. In: The Liver. pp. 218–268 (Hrsg. E. H. Gall u. F. K. Mostofi). Baltimore: Williams & Wilkins Comp. 1973.Google Scholar
  17. Kirn, A., Gut, J. P. T., Bingen, A., Hirth, C: Acute hepatitis produced by frog virus 3 in mice. Arch. Virusforsch. 36, 394 (1972).PubMedCrossRefGoogle Scholar
  18. Klenk, H.-D., Rott, R., Orlich, M., Blödorn, J.: Activation of influenza virus by trypsin treatment. Virology 68, 426 (1975).PubMedCrossRefGoogle Scholar
  19. McGavran, M. H., Easterday, B. C.: Rift Valley fever virus hepatitis. Light and electron microscopic studies in the mouse. Amer. J. Path. 42, 587 (1963).PubMedGoogle Scholar
  20. Mims, C. A.: An analysis of the toxicity for mice with influenza virus. Brit. J. exp. Path. 41, 593 (1960).PubMedGoogle Scholar
  21. Mims, C. A.: Aspects of the pathogenesis of virus disease. Bacteriol. Rev. 28, 30 (1964).PubMedGoogle Scholar
  22. Morris, T. Q., Gocke, D. J., Macaroc, V.: Exchange transfusion treatment of fulminating canine viral hepatitis: the role of specific antiviral antibodies. Gastroenterology 61, 885 (1971).PubMedGoogle Scholar
  23. Nagai, Y., Klenk, H.-D., Rott, R.: Proteolytic activation of virus specific glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 1976 (im Druck).Google Scholar
  24. Nowostawski, A., Krawczyniski, K., Brzosko, W. J.: Tissue localization of Australian antigen immune compleexes in acute and chronic hepatitis and liver cirrhosis. Amer. J. Path. 68, 31 (1972).Google Scholar
  25. Piazza, M.: Experimental viral hepatitis. Springfield, Illinois: C. C. Thomas, 1969.Google Scholar
  26. Porter, D. D., Larsen, A. E., Porter, H. G.: The pathogenesis of Aleuten disease of mink. J. exp. Med. 130, 575 (1969).PubMedCrossRefGoogle Scholar
  27. Porter, D. D., Porter, H. G., Deerhake, B. B.: Immunofluorescence assay for antigen and antibody in lactic dehydrogenase virus infection of mice. J. Immunol. 102, 431 (1969).PubMedGoogle Scholar
  28. Preisig, R., Gocke, D., Morris, T. Q.: Chronic hepatic injury following experimental viral hepatitis in the dog. Experientia 22, 701 (1966).PubMedCrossRefGoogle Scholar
  29. Rott, R., Becht, H.: Immunantwort bei Virusinfektionen. In: Handbuch der Virusinfektionen bei Tieren (Hrsg. H. Röhrer). Jena: VEB Gustav Fischer Verlag, 1976 (im Druck).Google Scholar
  30. Sabesin, S. M.: Effects of hydrocortisone on murine hepatitis virus replication and cell injury in cultured liver cells and macrophages. Am. J. Gastroenterology 57, 485 (1972).Google Scholar
  31. Sabesin, S. M., Koff, R. S.: Pathogenesis of experimental viral hepatitis. New Engl. J. Med. 944, 996 (1974).CrossRefGoogle Scholar
  32. Shif, I., Bang, F. B.: In vitro interaction of mouse hepatitis virus and macrophages from genetically resistant mice. J. exp. Med. 58, 607 (1970).Google Scholar
  33. Sturman, L. S., Takemoto, K. K.: Enhanced growth of a murine coronavirus in transformed mouse cells. Infect. and Immun. 6, 501 (1972).Google Scholar
  34. Tosolini, F. A., Mims, C. A.: Effect of murine strain and viral strain on the pathogenesis of lymphocytic choriomeningitis infection and a study of footpad responses. J. Infect. Dis. 123, 134 (1971).PubMedCrossRefGoogle Scholar
  35. Vella, P. P., Starr, T. J.: Effect of X radiation and cortisone on mouse hepatitis virus infection in germfree mice. J. Infect. Dis. 11, 271 (1965).CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1976

Authors and Affiliations

  • R. Rott
    • 1
  1. 1.Inst. f. VirologieUniv. GießenDeutschland

Personalised recommendations